6 Analysts Have This to Say About Adicet Bio
Portfolio Pulse from Benzinga Insights
In the last quarter, Adicet Bio (NASDAQ:ACET) received 2 bullish, 2 somewhat bullish, and 2 indifferent analyst ratings. The average price target is $25.17, compared to the current price of $2.18, implying an upside. The average price target has increased by 25.85% over the past month.
June 27, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Adicet Bio received mixed analyst ratings in the last quarter, with an average price target of $25.17, implying an upside from the current price of $2.18. The average price target increased by 25.85% over the past month.
The mixed analyst ratings indicate differing opinions on the stock's potential, but the average price target of $25.17 suggests an upside from the current price of $2.18. The increase in the average price target over the past month indicates growing optimism among analysts, which could positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100